Racial differences in response to cinacalcet as a treatment for uremic hyperparathyroidism

被引：0
|
作者：
Gupta, A
Heslin, KC
机构：
[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90059 USA
[2] Charles R Drew Univ Med & Sci, Sch Med, King Drew Med Ctr, Los Angeles, CA 90059 USA
来源：
KIDNEY INTERNATIONAL | 2006年 / 69卷 / 06期
关键词：
D O I：
10.1038/sj.ki.5000219
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1094 / 1094
页数：1
相关论文
共 50 条
  • [41] Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism
    Bergua, C.
    Torregrosa, J.-V.
    Cofan, F.
    Oppenheimer, F.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2254 - 2255
  • [42] Calciphylaxis resolved after treatment with cinacalcet HCI for secondary hyperparathyroidism
    Lindberg, JS
    Thezan, G
    Gabbard, W
    Tourgeman, K
    Husserl, F
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A25 - A25
  • [43] Utility of cinacalcet treatment in kidney transplant recipients with persistent hyperparathyroidism
    Akcay, Omer Faruk
    Yeter, Hasan Haci
    Guz, Galip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [44] The Efficacy of Cinacalcet in the Treatment of Hyperparathyroidism in Turkish Hemodialysis Patient Population
    Altunoren, Orcun
    Gungor, Ozkan
    Eren, Necmi
    Tanrisev, Mehmet
    Hur, Ender
    Turkmen, Kultigin
    Yavuz, Yasemin Coskun
    Sahin, Osman Zikirullah
    Saglam, Funda
    Turan, Mehmet Nuri
    Yaprak, Mustafa
    Ulutas, Ozkan
    Kocyigit, Ismail
    Oguz, Ayten
    Ari, Elif
    Ada, Sibel
    Yildiz, Abdulmecit
    Azak, Alper
    Korkmaz, Ahmet Edip
    Yavuz, Demet
    Dogan, Ibrahim
    Tekce, Hikmet
    Sert, Mehmet
    Kaya, Bulet
    Bakirdogen, Serkan
    Kose, Sennur
    Sakaci, Tamer
    Pembegul, Irem
    Aytug, Ferhan
    Guclu, Aydin
    Akgul, Bulent
    Yilmaz, Mahmut Ilker
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2016, 25 (02): : 192 - 198
  • [45] Treatment of secondary hyperparathyroidism with paricalcitol with or without cinacalcet in hemodialysis patients
    Zawierucha, Jacek
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Prystacki, Tomasz
    Marcinkowski, Wojciech
    Dryl-Rydzynska, Teresa
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (12): : 840 - 845
  • [46] Treatment With Cinacalcet in 29 Kidney Transplant Patients With Persistent Hyperparathyroidism
    Lopez, V.
    Toledo, R.
    Sola, E.
    Gutierrez, C.
    Sujan, S.
    Rodriguez, M. A.
    Cabello, M.
    Burgos, D.
    Gonzalez Molina, M.
    Hernandez, D.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2394 - 2395
  • [47] Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
    Aggarwal, H. K.
    Jain, Deepak
    Kaverappa, Vipin
    Kaushik, Sumin
    Yadav, Sachin
    RUSSIAN OPEN MEDICAL JOURNAL, 2013, 2 (03)
  • [48] Treatment of uremic hyperparathyroidism with percutaneous ethanol injection
    Fassi, J
    Lambertini, R
    Farias, P
    Blejman, O
    Rosa-Diez, G
    Algranati, S
    Plantalech, L
    NEPHRON CLINICAL PRACTICE, 2005, 101 (02): : C53 - C57
  • [49] The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
    Jaruwan Ngamkam
    Somratai Vadcharavivad
    Nutthada Areepium
    Titinun Auamnoy
    Kullaya Takkavatakarn
    Pisut Katavetin
    Khajohn Tiranathanagul
    Kearkiat Praditpornsilpa
    Somchai Eiam-Ong
    Paweena Susantitaphong
    Scientific Reports, 11
  • [50] MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM WITH CINACALCET
    Kostoglou-Athanassiou, I.
    Athanassiou, P.
    Xanthakou, E.
    Gkountouvas, A.
    Kaldrymides, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1077 - 1078
12345